After losing his mother to breast cancer and then fighting testicular cancer himself, Olympic gold medalist Scott Hamilton started a foundation to help those touched by the disease.
BY LAURA PANJWANI
PUBLISHED SEPTEMBER 15, 2016
Figure skater Scott Hamilton is perhaps best known for his signature backflip—a difficult move that few others can execute on ice.
But while the Olympic gold medalist has spent much of his career turning himself upside down, he now aims to turn cancer upside down. After losing his mother to breast cancer in 1977 and surviving his own battle with testicular cancer in 1997, Hamilton started the Scott Hamilton CARES Foundation, which is dedicated to funding world-class research and quality care to improve cancer survivorship. The logo for his foundation, an upside down ribbon, is a nod to his backflip and, more importantly, his goal to reverse the trajectory of cancer.
Scott Hamilton shares his thoughts about his Mothers Breast Cancer, his cancer and Proton Therapy.
The most recognized male figure skating star in the world, Scott Hamilton has won 70 titles, awards and honors including an Emmy Award nomination, induction into the United States OlympicHall of Fame and a privileged member of the World Figure Skating Hall of Fame. In 1984, he captured the attention of the world with his Olympic Gold medal performances in Saravejo and since has shared his love and enthusiasm for the sport as a commentator, performer, producer and best-selling author (Landing It & The Great Eight).
May 10, 2018
ERWIN, Tenn. – There's one last hope for Tennesseans who might benefit from a state-of-the-art cancer treatment.
Republican Gov. Bill Haslam vetoed the Cancer Patient Choice Act late last week, but there's talk of a possible special session to override his veto.
May 08, 2018 02:24 PM
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Governor Haslam’s statement regarding his veto of the Proton Therapy Access Act states that the Act “circumvents the established process for determining state employee insurance program coverage based on medical evidence and effectiveness.” According to Don Denton, President, Tennessee Cancer Patient Coalition, “State Executive Director of Benefits Administration, Laurie Lee, testified multiple times that her team lacks the resources and expertise to recommend or review coverage guidelines so they outsource those decisions to their insurance company and their insurer’s utilization manager, eviCore Healthcare Management. So, the established process the Governor refers to is simply outsourcing the decision to a third-party which has a vested interest in rationing healthcare. Relying on insurance companies to establish coverage guidelines for the latest therapies is obviously a flawed process for cancer patients given the disparity between eviCore’s proton therapy guidelines covering less than 5% of cancer incidence while Medicare covers over 70% of cancer incidence. This is clearly the case of the fox watching the hen house.”
Patients with Prostate, Other Urological Cancers Are 5 Times More Likely to Commit Suicide, UK Study Shows
This article is so sad. Exactly the reason we chose to do Proton Therapy.. The quality of life for a man is not good if they choose to do radiation or surgery. A way to minimize symptoms is to have Space Oars inserted before normal radiaion if proton therapy is not an option for you. This will help protect your vital organs from the damages of the radiation. Our doctor who wanted to do radiation never even mentioned this, so you will need to ask.
March 19, 2018
The issue of suicide risk among prostate cancer patients is back on the table again as a consequence of a presentation at the ongoing annual meeting of the European Association of Urology in Copenhagen, Denmark.
We had previously commented on prostate cancer and suicide back in 2009 and also in early 2010.
POSTED 7:06 AM, MAY 4, 2018, BY AP
NASHVILLE, Tenn. — Gov. Bill Haslam has vetoed legislation that would have required state employee insurance to cover proton therapy, an alternative treatment for certain cancers.
In a statement Thursday, the Republican governor said the legislation could put patients at risk and expose them to excessive charges from out-of-network providers.
The bill sponsored by Sen. Mark Green and Rep. Bob Ramsey, both Republicans, would have helped a Knoxville-based proton therapy company that plans to open another facility in Franklin.
Medical experts say the treatment reduces damage to surrounding tissue.
Haslam said the provider advocating for the bill rejected a medically appropriate plan to expand coverage and instead pursued a political mandate.
House Speaker Beth Harwell and Senate Speaker Randy McNally said it would be premature to call for a veto-override special session. Source Link
This is a great Site for information on Protons and everything related to it, including insurance help, which seems to be an issue for prostate cancer patients. Hopefully the things Bob mentions in his newsletter will help get that changed. We thank him for his help and resources he shares with us all. It is an excellent resource for all Proton Patients and those researching Proton therapy.
Published on Dec 7, 2012
Four men talk about their cancer diagnoses, how they decided to have proton therapy, and their experiences with proton therapy.
In an effort to help newly diagnosed men and shed light on the misinformation about proton therapy in the media, we ran a series of articles about the ten most common misrepresentations, or "myths," about proton therapy for prostate cancer. In our "Mythbuster Series" below, we set the record straight based on facts, published data, and our own patient surveys.
Proton therapy is as effective as standard photon or X-ray radiotherapy at treating the most common type of malignant brain tumor in children - and causes fewer long-term side effects.
Researchers found proton therapy is just as effective as conventional radiotherapy for treating pediatric medulloblastoma, and the treatment also causes fewer side effects.This was the conclusion of a trial led by Massachusetts General Hospital (MGH) in Boston and published in The Lancet Oncology.
News and Press Releases Proton Therapy